Schenectady, NY, United States of America

William A Boulanger


Average Co-Inventor Count = 6.7

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1996-2000

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of William A. Boulanger

Introduction

William A. Boulanger is a notable inventor based in Schenectady, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target viral infections. With a total of three patents to his name, Boulanger's work has the potential to impact the treatment of diseases such as HIV.

Latest Patents

Boulanger's latest patents include a method for the preparation of (.+-.)-calanolide A, a potent HIV reverse transcriptase inhibitor. This method involves the reaction of chromene 4 with acetaldehyde diethyl acetal or paraldehyde in the presence of an acid catalyst. The process can also be executed through a two-step reaction that includes an aldol reaction with acetaldehyde, leading to the production of chromanone 7. The reduction of chromanone 7 with sodium borohydride, in the presence of cerium trichloride, yields (.+-.)-calanolide A. Additionally, Boulanger has developed methods for resolving (.+-.)-calanolide A into its optically active forms and for treating or preventing viral infections using this compound.

Career Highlights

Throughout his career, Boulanger has worked with various companies, including Sarawak Medichem Pharmaceuticals, Inc. and Medichem Research, Inc. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in pharmaceutical research.

Collaborations

Boulanger has collaborated with notable individuals in his field, including Michael T. Flavin and Alla Kucherenko. These partnerships have likely enhanced his research and development efforts, leading to innovative solutions in the pharmaceutical industry.

Conclusion

William A. Boulanger's contributions to the field of pharmaceuticals, particularly through his patents related to (.+-.)-calanolide A, demonstrate his commitment to advancing medical science. His work has the potential to significantly impact the treatment of viral infections, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…